Sleep in Perimenopause and Menopause
Sleep disruption is one of the most common — and most disabling — symptoms of the menopause transition. Here is what changes, what HRT can and cannot do for it, and when something else needs to be ruled out.
This article is educational and is not medical advice. Consult your clinician before starting, stopping, or changing hormone therapy. Individual responses to HRT vary; the right hormones, doses, and delivery methods for you depend on your medical history and clinical context.
What changes about sleep
The most common perimenopausal sleep complaint is not trouble falling asleep — it is waking, often between 2 and 4am, and struggling to get back to sleep. Several mechanisms drive this: night-time hot flashes physically waking the patient; declining progesterone affecting sleep architecture (progesterone has sedating GABA-ergic activity); rising cortisol earlier in the night; and a contextual layer of mid-life anxiety that the earlier-waking patient is more likely to encounter than the well-sleeping patient.
What HRT can and cannot do
For the patient whose sleep disruption is driven primarily by night sweats, HRT often produces a striking improvement once the vasomotor symptoms are controlled. For the patient whose sleep disruption is driven by progesterone-mediated changes in sleep architecture, oral micronized progesterone taken at bedtime frequently improves sleep onset and continuity. For the patient whose sleep disruption is driven by anxiety, a sleep apnea pattern, or a circadian-rhythm issue, HRT may help indirectly but will not be the complete answer.
What needs to be ruled out
Obstructive sleep apnea is materially under-diagnosed in midlife women, in part because women present differently from the classic textbook description. A patient whose sleep does not improve with appropriate menopause care, who has new-onset snoring, who wakes unrefreshed, or whose bed partner has noticed pauses in breathing deserves a careful evaluation for sleep apnea before another medication is added.
Non-hormonal options
For patients who cannot or do not want to take HRT, non-hormonal options for menopause-related sleep disruption include gabapentin (off-label, particularly useful for night-time vasomotor symptoms), low-dose SSRIs and SNRIs, and cognitive behavioural therapy for insomnia (CBT-I), which has the strongest non-pharmacological evidence base of anything in the category. See non-hormonal options for the broader picture.
When you are ready to talk through your specific sleep picture with a clinician, find your menopause care options. The messaging-based model at Evernow tends to suit patients whose primary issue is sleep — written exchanges about what is working and what is not are well-suited to the iterative nature of getting this right.